David R. Bauer
Lawyers
Filters
NeuroPace $50 million at-the-market offering
The stock is listed on the Nasdaq Global Market
Forbion European Acquisition $138 million combination with enGene
We advised Forbion European Acquisition on its de-SPAC transaction
GSK exclusive license agreement for HS-20089 with Hansoh Pharma
We advised GSK on the transaction
GSK collaboration extension and new data licensing agreement with 23andMe
We advised GSK on the transaction
IDEAYA Biosciences $143.8 million equity offering
The common stock is listed on the Nasdaq Global Select Market
UCT acquisition of HIS Innovations Group
We advised UCT on the acquisition
Roche $7.1 billion acquisition of Telavant and rights to RVT 3101 from Roivant
We are advising Roche on the acquisition
Inventiva $58 million at-the-market offering
The American depositary shares are listed on Nasdaq
HilleVax $115 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
RayzeBio $358 million IPO
The stock is listed on the Nasdaq Global Market